- HK$878.03m
- HK$339.21m
- HK$1.55bn
- 68
- 81
- 54
- 79
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.54 | ||
| Price to Tang. Book | 0.54 | ||
| Price to Free Cashflow | 4.7 | ||
| Price to Sales | 0.58 | ||
| EV to EBITDA | 2.42 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -1.09% | ||
| Return on Equity | -0.79% | ||
| Operating Margin | -1.25% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | HK$m | 2,064.88 | 2,273.4 | 1,601.43 | 1,449.34 | 1,553.24 | n/a | n/a | -7.37% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +21.25 | +25.03 | -97.15 | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Lung Kee Group Holdings Ltd, formerly Lung Kee (Bermuda) Holdings Ltd, is an investment holding company mainly engaged in the manufacturing and marketing of mould bases business. The Company is mainly engaged in the manufacturing and marketing of mould bases and related products. The Company is also engaged in the provision of enterprise management services. The Company sells its products in China, America and Europe.
Directors
- Tit Lung Siu CHM (64)
- Yuk Lung Siu MDR (61)
- Yu Hang Siu EDR (37)
- Yuk Tung Siu EDR (37)
- Chung Ho Ting EDR (61)
- Lung Shing Wai SEC (53)
- Joo Hai Lee NID
- Tat Yee Lee NID (67)
- Wing Ting Stephen Liu NID (62)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- December 3rd, 1992
- Public Since
- March 5th, 1993
- No. of Employees
- 3,000
- Sector
- Machinery, Equipment & Components
- Industry
- Industrials
- Exchange
Stock Exchange of Hong Kong Limited- Shares in Issue
- 631,677,303
- Address
- 20th Floor, Crocodile Center,
- Web
- Phone
- Auditors
- Deloitte Touche Tohmatsu
Upcoming Events for 255
Dividend For 0255.HK - 0.0600 HKD
Dividend For 0255.HK - 0.1200 HKD
Lung Kee (Bermuda) Holdings Ltd Annual Shareholders Meeting
Similar to 255
Aceso Life Science
Stock Exchange of Hong Kong Limited
Acme International Holdings
Stock Exchange of Hong Kong Limited
Best Linking group
Stock Exchange of Hong Kong Limited
Bortex Global
Stock Exchange of Hong Kong Limited
CALB Co
Stock Exchange of Hong Kong Limited
FAQ
What is the Lung Kee group share price?
As of Today at 21:50 UTC, shares in Lung Kee group are trading at HK$1.42. This share price information is delayed by 15 minutes.
How has the Lung Kee group share price performed this year?
Shares in Lung Kee group last closed at HK$1.42 and the price had moved by +19.33% over the past 365 days. In terms of relative price strength the Lung Kee group share price has outperformed the FTSE Developed Asia Pacific Index by +20.69% over the past year.
What are the analyst and broker recommendations for Lung Kee group?
There is no consensus recommendation for this security.
Find out moreWhat is the Lung Kee group dividend yield?
The Lung Kee group dividend yield is 7.75% based on the trailing twelve month period.
Does Lung Kee group pay a dividend?
Last year, Lung Kee group paid a total dividend of HK$0.11, and it currently has a trailing dividend yield of 7.75%.Looking ahead, shares in Lung Kee group are due to go ex-dividend on 2025-05-23 and the next dividend pay date is 2025-06-09.
When does Lung Kee group next pay dividends?
Lung Kee group are due to go ex-dividend on 2025-05-23 and the next dividend pay date is 2025-06-09. The historic dividend yield on Lung Kee group shares is currently 7.75%.
How do I buy Lung Kee group shares?
To buy shares in Lung Kee group you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Lung Kee group?
As of the previous close price of HK$1.42, shares in Lung Kee group had a market capitalisation of HK$878.03m.
Where are Lung Kee group shares listed?
Here are the trading details for Lung Kee group:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 255
What kind of share is Lung Kee group?
Based on an overall assessment of its quality, value and momentum Lung Kee group is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Lung Kee group share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Lung Kee group share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Lung Kee group. Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +25.39%.
As of the last closing price of HK$1.42, shares in Lung Kee group were trading +16.93% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Lung Kee group PE Ratio?
The Lung Kee group PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at HK$1.42.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Lung Kee group?
Lung Kee group's management team is headed by:
- Tit Lung Siu - CHM
- Yuk Lung Siu - MDR
- Yu Hang Siu - EDR
- Yuk Tung Siu - EDR
- Chung Ho Ting - EDR
- Lung Shing Wai - SEC
- Joo Hai Lee - NID
- Tat Yee Lee - NID
- Wing Ting Stephen Liu - NID